Pixelgen Technologies Closes $15.5M Oversubscribed Series B to Accelerate Global Expansion

Life sciences leaders Ramon Felciano and Rickard El Tarzi join board as company scales commercialization of its molecular cell architecture platform STOCKHOLM, Aug. 20, 2026 /PRNewswire/ -- Pixelgen Technologies, developer of the first high-throughput platform for mapping molecular cell...